Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?

Drug resistance is a major cause for therapeutic failure in non-small cell lung cancer (NSCLC) leading to tumor recurrence and disease progression. Cell intrinsic mechanisms of resistance include changes in the expression of drug transporters, activation of pro-survival, and anti-apoptotic pathways,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosa Iglesias, Venus, Giuranno, Lorena, Dubois, Ludwig J., Theys, Jan, Vooijs, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066509/
https://www.ncbi.nlm.nih.gov/pubmed/30087852
http://dx.doi.org/10.3389/fonc.2018.00267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066509/
https://www.ncbi.nlm.nih.gov/pubmed/30087852
http://dx.doi.org/10.3389/fonc.2018.00267

Ejemplares similares